| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |